← Back to Search

Fast Track Intervention for Conduct Disorder

N/A
Waitlist Available
Led By Robert J McMahon, PhD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must be in 1st grade
Be younger than 18 years old
Must not have
Cannot be older than 1st grade
Timeline
Screening 3 weeks
Treatment Varies
Follow Up grades 10-12 and ages 19, 20, 25, 32, and 34
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether a comprehensive intervention can prevent severe conduct problems in high-risk children.

Who is the study for?
This trial is for first graders in public schools at 4 study sites, identified as high-risk for severe conduct problems. Children must score in the top 40% on the TOCA-R assessment. Those older than first grade are not eligible.
What is being tested?
The 'Fast Track' program aims to prevent chronic conduct issues among high-risk children. It will be tested if this intervention positively impacts behavior and prevents negative outcomes like delinquency or school dropout.
What are the potential side effects?
Since 'Fast Track' is a behavioral intervention rather than a medication, it may not have typical medical side effects but could include changes in mood or behavior as children adapt to the program.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am currently in the 1st grade.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am in kindergarten or 1st grade.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~grades 10-12 and ages 19, 20, 25, 32, and 34
This trial's timeline: 3 weeks for screening, Varies for treatment, and grades 10-12 and ages 19, 20, 25, 32, and 34 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Anti-Social Behaviors
Secondary study objectives
Academic Achievement
Characteristics/Behaviors of Participants' Offspring
Family Formation and Romantic Partnerships
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Fast Track EligibleExperimental Treatment1 Intervention
Participants in the Experimental group received the "Fast Track" intervention. Intervention included school-based curriculum attended by high-risk children, parents, program staff, and occasionally teachers, home visiting, the the in-class PATHS prevention program.
Group II: Control GroupActive Control1 Intervention
Participants in the Control group were not eligible to receive the Fast Track intervention. These children received other services as usual, and served as the randomized comparison group for examining Fast Track program impacts

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
2,928 Previous Clinical Trials
2,744,128 Total Patients Enrolled
17 Trials studying Conduct Disorder
5,524 Patients Enrolled for Conduct Disorder
National Institute on Drug Abuse (NIDA)NIH
2,594 Previous Clinical Trials
3,327,845 Total Patients Enrolled
5 Trials studying Conduct Disorder
1,548 Patients Enrolled for Conduct Disorder
U.S. Department of EducationFED
86 Previous Clinical Trials
53,841 Total Patients Enrolled
Duke UniversityLead Sponsor
2,458 Previous Clinical Trials
2,968,558 Total Patients Enrolled
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,061 Previous Clinical Trials
2,744,257 Total Patients Enrolled
1 Trials studying Conduct Disorder
150 Patients Enrolled for Conduct Disorder
Robert J McMahon, PhDPrincipal InvestigatorSimon Fraser University
Ellen E Pinderhughes, PhDPrincipal InvestigatorTufts University
John E Lochman, PhDPrincipal InvestigatorUniversity of Alabama at Birmingham
Daniel M Crowley, PhDPrincipal InvestigatorPenn State University
Karen L Bierman, PhDPrincipal InvestigatorPenn State University

Media Library

Fast Track Clinical Trial Eligibility Overview. Trial Name: NCT01653535 — N/A
Conduct Disorder Research Study Groups: Fast Track Eligible, Control Group
Conduct Disorder Clinical Trial 2023: Fast Track Highlights & Side Effects. Trial Name: NCT01653535 — N/A
Fast Track 2023 Treatment Timeline for Medical Study. Trial Name: NCT01653535 — N/A
~98 spots leftby Mar 2029